These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33418337)

  • 1. A comparative study on biological characteristics of ten coxsackievirus A10 virus strains.
    Gao W; Yue L; Yang T; Li H; Song X; Xie T; He X; Xie Z
    Virology; 2021 Mar; 555():1-9. PubMed ID: 33418337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine.
    Gao W; Yue L; Yang T; Shen D; Li H; Song X; Xie T; He X; Xie Z
    Biomed Pharmacother; 2021 Nov; 143():112212. PubMed ID: 34649345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.
    Shen C; Liu Q; Zhou Y; Ku Z; Wang L; Lan K; Ye X; Huang Z
    Vaccine; 2016 Sep; 34(41):5005-5012. PubMed ID: 27562093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
    Jin WP; Lu J; Zhang XY; Wu J; Wei ZN; Mai JY; Qian SS; Yu YT; Meng SL; Wang ZJ; Shen S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of coxsackievirus A10 strains isolated from children with hand, foot, and mouth disease.
    Zhang J; Xu D; Liu H; Zhang M; Feng C; Cong S; Sun H; Yang Z; Ma S
    J Med Virol; 2022 Feb; 94(2):601-609. PubMed ID: 34387895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of the biological characteristics of three CV-A10 clones adaptively cultured on Vero cells.
    Zhao H; Yang T; Yue L; Li H; Xie T; Xiang H; Wang J; Wei X; Zhang Y; Xie Z
    J Med Virol; 2022 Aug; 94(8):3820-3828. PubMed ID: 35437759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice.
    Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C
    Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model.
    Qian SS; Wei ZN; Jin WP; Wu J; Zhou YP; Meng SL; Guo J; Wang ZJ; Shen S
    Emerg Microbes Infect; 2021 Dec; 10(1):763-773. PubMed ID: 33739899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection.
    Zhou Y; Zhang C; Liu Q; Gong S; Geng L; Huang Z
    Antiviral Res; 2018 Apr; 152():124-130. PubMed ID: 29470994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
    Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW
    Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10.
    Zhu R; Xu L; Zheng Q; Cui Y; Li S; He M; Yin Z; Liu D; Li S; Li Z; Chen Z; Yu H; Que Y; Liu C; Kong Z; Zhang J; Baker TS; Yan X; Hong Zhou Z; Cheng T; Xia N
    Sci Adv; 2018 Sep; 4(9):eaat7459. PubMed ID: 30255146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system.
    Lien SC; Shen YS; Lin HY; Wu SR; Fang CY; Chen CH; Chen YA; Chong PC; Huang MH; Chow YH; Wang JR; Wu SC; Liu CC
    Virus Res; 2023 May; 329():199101. PubMed ID: 36958398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo.
    Yao X; Mao Q; Li Y; Hao C; Bian L; Chen P; Gao F; Wu X; Lu W; Gao Q; Li X; Liang Z
    Hum Vaccin Immunother; 2018 May; 14(5):1275-1282. PubMed ID: 29337652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
    Zhang Z; Dong Z; Wang Q; Carr MJ; Li J; Liu T; Li D; Shi W
    Vaccine; 2018 Nov; 36(46):7095-7104. PubMed ID: 30316529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation.
    Li S; Zhao H; Yang L; Hou W; Xu L; Wu Y; Wang W; Chen C; Wan J; Ye X; Liang Z; Mao Q; Cheng T; Xia N
    Antiviral Res; 2017 Aug; 144():247-255. PubMed ID: 28625478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle destruction caused by coxsackievirus A10 in gerbils: Construction of a novel animal model for antiviral evaluation.
    Chen C; Xia Y; Zhu S; Xu F; Sun Y; Lu H; Gao M; Yang Z; Mao Z; Ge Q; Miao Z; Zhu H; Yao P
    Virus Res; 2020 Sep; 286():198067. PubMed ID: 32553610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Coxsackievirus A6 Strains Isolated From Children With Hand, Foot, and Mouth Disease.
    Liu H; Zhang M; Feng C; Cong S; Xu D; Sun H; Yang Z; Ma S
    Front Cell Infect Microbiol; 2021; 11():700191. PubMed ID: 34490141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.